Rilei Yu

3.3k total citations · 1 hit paper
128 papers, 2.4k citations indexed

About

Rilei Yu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Rilei Yu has authored 128 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 19 papers in Organic Chemistry and 15 papers in Oncology. Recurrent topics in Rilei Yu's work include Nicotinic Acetylcholine Receptors Study (40 papers), Receptor Mechanisms and Signaling (36 papers) and Ion channel regulation and function (19 papers). Rilei Yu is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (40 papers), Receptor Mechanisms and Signaling (36 papers) and Ion channel regulation and function (19 papers). Rilei Yu collaborates with scholars based in China, Australia and Thailand. Rilei Yu's co-authors include Tao Jiang, Quentin Kaas, David J. Craik, David J. Adams, Aihua Jin, Sébastien Dutertre, Han‐Shen Tae, Christopher G. Proud, Xiguang Chen and Tingting Qiu and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Rilei Yu

122 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathophysiology of obesity and its associated diseases

2023 214 citations Rilei Yu, Tao Jiang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rilei Yu China	25	1.6k	262	208	198	186	128	2.4k
Ganesha Rai United States	26	1.3k 0.8×	311 1.2×	118 0.6×	98 0.5×	151 0.8×	90	2.2k
Mario A. Pagano Italy	29	1.9k 1.2×	316 1.2×	148 0.7×	152 0.8×	118 0.6×	70	2.8k
Peter Chase United States	24	1.2k 0.7×	224 0.9×	214 1.0×	151 0.8×	62 0.3×	68	2.0k
S. Adrian Saldanha United States	22	1.5k 0.9×	233 0.9×	220 1.1×	142 0.7×	79 0.4×	32	2.2k
Mauro Salvi Italy	31	2.3k 1.4×	120 0.5×	206 1.0×	257 1.3×	157 0.8×	94	3.1k
HaJeung Park United States	27	1.7k 1.0×	264 1.0×	270 1.3×	111 0.6×	99 0.5×	68	2.4k
Huihao Zhou China	22	1.6k 1.0×	158 0.6×	103 0.5×	77 0.4×	163 0.9×	99	2.2k
Seungil Han United States	27	1.6k 1.0×	261 1.0×	184 0.9×	99 0.5×	175 0.9×	50	2.8k
Abdellah Allali‐Hassani Canada	34	3.3k 2.0×	220 0.8×	135 0.6×	142 0.7×	118 0.6×	60	4.1k
P. Loppnau Canada	28	2.1k 1.3×	122 0.5×	136 0.7×	127 0.6×	92 0.5×	54	2.7k

Countries citing papers authored by Rilei Yu

Since Specialization

Citations

This map shows the geographic impact of Rilei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rilei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rilei Yu more than expected).

Fields of papers citing papers by Rilei Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rilei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rilei Yu. The network helps show where Rilei Yu may publish in the future.

Co-authorship network of co-authors of Rilei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Rilei Yu. A scholar is included among the top collaborators of Rilei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rilei Yu. Rilei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Su, Jiawei, Zixuan Zhang, Jun Zhao, et al.. (2025). Molecular insights into the α6β4 nicotinic acetylcholine receptor function and ligand recognition. Nature Communications. 16(1). 3153–3153.

Zhao, Jun, Jinghui Zhang, Shujing Xu, et al.. (2024). Transport and inhibition mechanisms of the human noradrenaline transporter. Nature. 632(8026). 930–937. 14 indexed citations

Zang, Ruochen, Liang Xue, Meifang Zhang, et al.. (2023). Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist. European Journal of Medicinal Chemistry. 250. 115184–115184. 13 indexed citations

Ge, Cheng, Xuejie Wang, Peta J. Harvey, et al.. (2023). Designing antimicrobial peptides using deep learning and molecular dynamic simulations. Briefings in Bioinformatics. 24(2). 63 indexed citations

Guo, Feifei, Tong Li, Xue Zhang, et al.. (2023). Electrochemical detection of the oxidative damage of a potential pyrimido[5,4-g]pteridine-derived antitumor agent toward DNA. Analytical and Bioanalytical Chemistry. 415(12). 2249–2260. 1 indexed citations

Chu, Yanyan, et al.. (2023). Molecular Dynamic Simulations Reveal the Activation Mechanisms of Oxidation-Induced TRPV1. International Journal of Molecular Sciences. 24(11). 9553–9553.

Li, Tong, Feifei Guo, Ping Sun, et al.. (2023). Electrochemical detection of genetic damage caused by the interaction of novel bifunctional anthraquinone-temozolomide antitumor hybrids with DNA modified electrode. Journal of Pharmaceutical and Biomedical Analysis. 231. 115410–115410. 2 indexed citations

Song, Nannan, Siqi Zhang, Xuekai Wang, et al.. (2023). Discovery of a pyrrole-pyridinimidazole derivative as novel SIRT6 inhibitor for sensitizing pancreatic cancer to gemcitabine. Cell Death and Disease. 14(8). 499–499. 18 indexed citations

Li, Mingfeng, et al.. (2022). A novel inhibitor of PGK1 suppresses the aerobic glycolysis and proliferation of hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 158. 114115–114115. 24 indexed citations

10.

Wang, Shuo, Peter H. Bartels, Cong Zhao, et al.. (2022). A 4/8 Subtype α-Conotoxin Vt1.27 Inhibits N-Type Calcium Channels With Potent Anti-Allodynic Effect. Frontiers in Pharmacology. 13. 881732–881732. 1 indexed citations

11.

Zhang, Guorui, Guanzhao Wu, Xin Qi, et al.. (2022). Design, synthesis, and biological evaluation of novel 7-substituted 10,11-methylenedioxy-camptothecin derivatives against drug-resistant small-cell lung cancer in vitro and in vivo. European Journal of Medicinal Chemistry. 241. 114610–114610. 18 indexed citations

12.

Tang, Wei, Xin Qi, Rilei Yu, et al.. (2021). PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells. Cancer Biology and Medicine. 19(4). 486–503. 12 indexed citations

13.

Wei, Ningning, et al.. (2021). Antagonistic Mechanism of α-Conotoxin BuIA toward the Human α3β2 Nicotinic Acetylcholine Receptor. ACS Chemical Neuroscience. 12(24). 4535–4545. 4 indexed citations

14.

Liu, Rui, Jaebeom Lee, Jingyi Li, et al.. (2021). Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets. Molecular Cell. 81(13). 2722–2735.e9. 96 indexed citations

15.

Yu, Rilei, Huijie Liu, Baishi Wang, et al.. (2020). Synthesis and biological activity study of the retro-isomer of RhTx against TRPV1. RSC Advances. 10(4). 2141–2145. 6 indexed citations

16.

Sun, Xiaohua, et al.. (2020). Identification of inhibitors targeting HIF-2α/c-Myc by molecular docking and MM-GBSA technology. Journal of Receptors and Signal Transduction. 41(5). 511–519. 3 indexed citations

17.

Sun, Xiaohua, et al.. (2020). Study on the interactions of pyrimidine derivatives with FAK by 3D-QSAR, molecular docking and molecular dynamics simulation. New Journal of Chemistry. 44(45). 19499–19507. 6 indexed citations

18.

Zhang, Siqi, Qiaoling Song, Xueting Wang, et al.. (2019). Virtual Screening Guided Design, Synthesis and Bioactivity Study of Benzisoselenazolones (BISAs) on Inhibition of c-Met and Its Downstream Signalling Pathways. International Journal of Molecular Sciences. 20(10). 2489–2489. 8 indexed citations

19.

Xin, Lan-Ting, Lu Liu, Chang‐Lun Shao, et al.. (2017). Discovery of DNA Topoisomerase I Inhibitors with Low-Cytotoxicity Based on Virtual Screening from Natural Products. Marine Drugs. 15(7). 217–217. 23 indexed citations

20.

Zhang, Renshuai, Shaopeng Chen, Xiaowei Zhang, et al.. (2016). Synthesis and evaluation of novel non-covalent binding quinazoline glycoside derivatives targeting the L858R and T790M variants of EGFR. RSC Advances. 6(43). 36857–36862. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact